// App-Quantinova.ai

: PDTM-28. AN OTX2-PAX3 SIGNALLING AXIS REGULATES GROUP 3 MEDULLOBLASTOMA CELL FATE

Researchers

Presenter

  • Jennifer Chan

Principal Investigators

  • Olivier Saulnier

  • Maria Vladoiu

  • Michael Taylor

  • Vijay Ramaswamy

  • Tamra Werbowetski-Ogilvie

Medical Centers

  • University of Calgary, Calgary, AB, Canada

  • University of Toronto, Toronto, ON, Canada

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Medulloblastoma

Biomarkers

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved